Conferences  >  Medicine & Healthcare  >  Pharmacology and Drug Development

Virtue Insight

After the successful journey of a series of 34 Pharmacovigilance conferences, Virtue Insight is proud to announce its 35th Pharmacovigilance 2024. We have been delivering the conference through close collaboration with the industry leaders for more than a decade. For the 2024 edition, the agenda includes a host of new and exciting features. Take a chance and make it count by attending this conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level.

Email: Kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

Medicine (in general), Internal medicine,    Regulation in Medicine and Pharmacology

For the forthcoming conference, we will be continuing with debates, and we will provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Target Conferences Ltd.;     Phone: [+972 3 517 5150];     Email: eilat@target-conferences.com

Eilat, epilepsy, conference, antiepileptic, drugs, research, treatment, devices

Royal Society of Chemistry

With the ever-growing prevalence of drug-resistant pathogens, it has never been more important that we refresh the drug pipeline with new antimicrobials that act on new targets or exhibit novel modes of action. The recent COVID pandemic has served to highlight the importance of developing effective treatments for infection, driving the recent resurgence in anti-infectives drug discovery and development of innovative technologies and approaches for combating infection through more effective detection and diagnosis methods.

Pharma Partnering Summit

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specializing in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.

Phone: [The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from di;     Email: taiba@pharma-partneirng-summit.co.uk

Business Development, Licensing, Alliances, Collaboration, Partnership, External Innovation, Search and evaluation, M&A, Pharma biotech Year.

Pharma Partnering Summit

Welcome to the Digital Health Envision Summit, where the future of healthcare comes to life! Join us as we bring together Dealmakers, Innovators, Investors, and Decision-makers from the Pharma & Biotech sector to explore the transformative potential of Digital Health therapies and technologies. This Summit is the ultimate platform for discovering new products, unlocking business opportunities, fostering collaboration, and igniting innovation in the industry.

Immerse yourself in a dynamic environment where Big, Midsize, and Small Pharma & Biotech companies come together to showcase their cutting-edge assets, revolutionary products, ground-breaking technologies, innovative platforms, and game-changing services. Connect with potential Partners and visionary minds who share your passion for driving innovation and shaping the future of healthcare.

Phone: [441753253192];     Email: taiba@pharma-partneirng-summit.co.uk

Digital Health, Business development, Partnership, Innovation, Real world, Digital neurology, Digital therapeutics, Drug discovery, Regulatory affairs, Artificial Intelligence, Machines learning, Data analytics, Decision Health, BAB, Oral health

FDAMap

FDA now requires all DMFs be submitted only in the electronic CTD format which creates a huge burden on owners of most submissions. Converting to eCTD format requires special skills, software and resources, the cost of which could be prohibitive to small manufacturers. Our speaker, Dr. Mukesh Kumar, in this workshop will go over the details of the latest guidance on eCTD submission and explain the key takeaways.

E CTD, E CTD Submissions, FDA Compliance, FDA Regulation

Regulation in Medicine and Pharmacology,    Translational Medicine, Clinical Trials

Pharma Partnering Summit

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.

Phone: [441753253192];     Email: taiba@pharma-partneirng-summit.co.uk

FDAMap

SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. They are frequently poorly written, communicated, monitored and enforced. This workshop will provide step by step instructions to create SOPs for FDA-regulated organizations.

FDA, SOPs, Quality Management System, Clinical Trials, Clinical Studies, Clinical Research, Clinical Development, FDA Regulation, FDA Complience

Regulation in Medicine and Pharmacology,    Translational Medicine, Clinical Trials

FDAMap

Each year FDA receives about 3000 applications for new devices via the 510k process, and about 60% of them are rejected either for poor quality application that cannot even be reviewed or for other technical reasons. Submissions to the FDA that are poorly organized, do not follow current practices, contain inconsistencies between documents, have missing or incomplete content, or poor structure will result in significant delays in the clearance process. With multiple review cycles, up to 90 days each, rejections by FDA could stretch the 510k clearance time-lines to 8 months or more. Most of the refuse-to-accept deficiencies are due to the inexperience of the 510k writers, who ignore the FDA rules. Writing and assembling a complete and well structured 510(k) submission will certainly improve the likelihood of FDA clearance on the first round.

This hands-on workshop is done by one of the industry’s top regulatory expert. The trainer has performed numerous reviews of 510(k) submissions over the last 15 years, and has analyzed the reasons that most often lead to delays in getting submissions ultimately cleared by FDA. This hands-on workshop will walk the attendees through the structure and key elements of the 510(k) submission and explains in clear language the most common pitfalls to avoid in the development of your 510(k) submission to the FDA.

FDA, 510 K Submission, 510 K Writers, FDA Compliance, FDA Regulations,

Regulation in Medicine and Pharmacology,    Translational Medicine, Clinical Trials

Scientific Update Ltd.

Professional Training Events in Chemistry,    Biochemistry and Medicinal Chemistry, Toxicology

Fusion Conferences

This conference aims to include recent progress in translating human genetic discoveries into functional characterization of genome wide association study (GWAS) regions that encode risk for complex human diseases. This symposium will highlight a number of exemplary functional studies of GWAS loci, examine how single cell data can accelerate translation of genetic associations, and how we can expand our catalogs of causal genes using the new CRISPR-Cas9 screening tools.

Pharmacogenomics, Personalized Medicine,    Genomics and Bioinformatics

INDIAN EXHIBITION SERVICES

This Expo an International Exhibition & Conference on Pharma- Healthcare- Technologies focuses on Future of Pharma & Healthcare Industries to be converting in a Pure Digital Renovating Worldwide.

All the professionals from across the globe will converge to share their knowledge, leading to the future assets. To create an international event which will be a focused and dedicated platform for professionals from major industries like Pharma, IT, Healthcare, & Start-ups to discuss, and share knowledge, expertise and experience.

The Expo & conference is expected to be attended by more than 500 delegates & 400 + Exhibitor across the Globe, including researchers, Healthcare & Pharma Technology authorities, and enforcement agencies, practitioners, policymakers, industry representatives, academicians and students working in the fields of life Science, Technology and Healthcare.

To discuss on potential solutions and researches that will highlight current science, management issues and new directions benefiting the industry in various regions.

Public sector, private industry and service providers are rapidly transforming with technology commotions and integrations. We understand and analyse the trends and collaborate with the government to provide a better service to Industry Stakeholders.

Technology upgradation in Pharma & Healthcare sectors through right tools and technologies is imperative. Our offerings bridge the gap for solution providers, regulators, Policymakers and educators, facilitating creation of the new world order in the Pharma & Healthcare Technical spectrum.

Pharma India Expo - the leading International Exhibition & Conference on Pharma- Healthcare- Technologies Industries- is the perfect place for the open to networking, exchange of knowledge, ideas and information. The industry meeting of the year offers an overview for the entire Industry Expert of all important findings and innovations in the industry

Discover the products, services and solutions from around 400+ exhibitors. Experience a compact, certified lecture program with over 200 contributions from more than 100 speakers and gain a lot of knowledge in a short time. Exchange ideas with colleagues and expand your network with new, valuable contacts, which takes place parallel to Pharma India Expo, health politicians and professional representatives set the course for the future of the industry.

PHARMA INDIA EXPO;     Phone: [08448193089];     Email: milan@ies-india.com

pharma, pharmaceutical, expo, industry,

Banff International Research Station (BIRS) for Mathematical Innovation and Discovery

Drug design and development are costly and lengthy. Mathematical and computational modelling anchored in model-informed drug development (MIDD) and quantitative systems pharmacology (QSP) methodologies are integral to accelerating the R&D pipeline. In parallel, MIDD and QSP can be used to better understand the biological basis of drug responses and fuel new biomedical research paths. This workshop will bring together experts in the fields of MIDD and QSP with the goal of strengthening ties between industrial and academic researchers and advancing these exciting fields.

Modeling and Simulation,    Applied Mathematics (in general)

i Pharma Expo

iPharma Expo 2024, USA (International Pharmaceutical Business Expo 2024) scheduled during August 16- 17, 2024 , at Boston, USA.

Phone: [(617) 275-2612];     Email: kathy@ipharmaexpo.net

Pharma Expo, pharma congress, pharma Expo USA, pharmaceutical event, pharma USA, pharmaceutical expo, international pharma, iPharma USA

Microtechnology, Nanotechnology,    Clusters, Nanomaterials, Graphene and Fullerenes

In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary. The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure. The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.

Infectious Disease Medicine,    Epidemiology & Public Health

ILAE-Europe

The Course is held under the auspices of the ILAE Europe. The program is designed for junior researchers and clinicians (45 years and younger) working in the field of epilepsy treatment and related basic research. It is open to young neurologists, neuropediatricians, pharmacists, pharmacologists, neuropsychologists and neuroscientists. We are happy to inform you that a number of bursaries have been made available towards partially defraying the cost of accommodation expenses of bursary recipients, who will also have their registration fees waived.

Target Conferences Ltd.;     Phone: [+972 3 517 5150];     Email: eilatedu@target-conferences.com

Eilat, epilepsy, course, education, treatment, drugs, pharma, pharmacological, international, research

Oxford Global Conferences

Discover the latest advancements in biomarkers at the 8th Annual Biomarker & Precision Medicine US Congress. Join experts from global pharma, top biotechs, and renowned academic institutions to delve into emerging tools and strategies in translational science, diagnostics, and biomarker development.

Marketing Executive;     Email: l.staplehurst@oxfordglobal.com

Novel Biomarker Discovery, Identification & Characterization, Effective Clinical Biomarker Strategies, Multi-Omics For Precision Medicine, Emerging Strategies For Biomarker Validation & Data Analysis, High-Quality Biospecimens in Clinical Development & Precision Medicine, Innovative Tools & Technologies For Next-Gen Diagnostics

Noveltics Group LLC

Welcome to the forefront of pharmaceutical innovation! Noveltics Group is thrilled to invite you to the International Pharma Congress which is going to be held during November 18-19, 2024 at Dubai, UAE , where groundbreaking discoveries, transformative technologies, and visionary leaders converge to shape the future of healthcare.

Phone: [ +1-765-545-2593];     Email: advancedpharma@researcherstalk.com

Pharmacology, Drug Discover, Drug Development, Pharmaceutical Chemistry, Pharmacognosy, Natural Products, Medicinal Plants

MDPI

The IECV 2024 invites researchers from academia, as well as vaccine practitioners, to contribute original findings, novel ideas, scientific concepts, and new technologies and experiences to deal with immunology mechanisms, animal models for immunologic diseases, viral immunology, immunopathogenesis, vaccine development and efficacy evaluation, immune responses to vaccines, vaccine technology, vaccine vectors, adjuvants, and immunomodulators.

Email: iecv2024@mdpi.com

Immunology Mechanisms, Animal Models for Immunologic Diseases, Viral Immunology, Immunopathogenesis, Vaccine Development and Efficacy Evaluation, Immune Responses to Vaccines, Vaccine Technology, Vaccine Vectors Adjuvants and Immunomodulators